
FDA creates import alert system for GLP-1 ingredients to protect patients
Investing.com -- The U.S. Food and Drug Administration established a "green list" import alert on Friday to block potentially dangerous GLP-1 active pharmaceutical ingredients from unverified foreign sources entering the U.S. market. This measure aims to protect consumers from illegal GLP-1 ingredients imported from overseas, ensuring patient safety and maintaining a secure drug supply chain. GLP- ...